Compounds > gemcitabine
Page last updated: 2024-08-24

gemcitabine and pirarubicin

gemcitabine has been researched along with pirarubicin in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Chen, YT; Hong, GB; Jiang, RJ; Luo, JH; Xu, LF; Xu, LY; Zhou, JX1
He, A; Huang, Y; Qi, W; Shen, Z; Sun, Y; Yang, Y; Yao, Y; Zhao, H1
Diao, WL; Guo, HQ; Wang, TW; Yang, R; Yuan, H; Zhao, XZ1
Niu, X; Wang, T; Zhong, B1
Chen, Q; Fu, D; Huang, S; Li, H; Li, Z; Luo, Q; Wang, L; Wang, Z; Xue, L; Zhang, P1

Other Studies

5 other study(ies) available for gemcitabine and pirarubicin

ArticleYear
[Efficacy of selective continuous transarterial infusion chemotherapy on advanced pancreatic cancer].
    Ai zheng = Aizheng = Chinese journal of cancer, 2004, Volume: 23, Issue:12

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Deoxycytidine; Doxorubicin; Female; Fluorouracil; Gemcitabine; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Leucovorin; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Remission Induction; Survival Rate

2004
Comparison of pirarubicin-based versus gemcitabine-docetaxel chemotherapy for relapsed and refractory osteosarcoma: a single institution experience.
    International journal of clinical oncology, 2013, Volume: 18, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Deoxycytidine; Disease-Free Survival; Docetaxel; Doxorubicin; Drug-Related Side Effects and Adverse Reactions; Female; Gemcitabine; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Middle Aged; Osteosarcoma; Prospective Studies; Taxoids

2013
Comparison of gemcitabine and anthracycline antibiotics in prevention of superficial bladder cancer recurrence.
    BMC urology, 2019, Oct-15, Volume: 19, Issue:1

    Topics: Aged; Anthracyclines; Antineoplastic Agents; Deoxycytidine; Doxorubicin; Epirubicin; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Treatment Outcome; Urinary Bladder Neoplasms

2019
Molecular classification of patients with NMIBC predicts the efficacy of intravesical chemotherapy with pirarubicin, pharmorubicin and gemcitabine-immunohistochemistry-based classification.
    Japanese journal of clinical oncology, 2022, May-31, Volume: 52, Issue:6

    Topics: Administration, Intravesical; Anthracyclines; Antibiotics, Antineoplastic; Deoxycytidine; Doxorubicin; Epirubicin; Gemcitabine; Humans; Immunohistochemistry; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms

2022
The application of gemcitabine and pirarubicin in patients with non-muscle invasive bladder cancer.
    Journal of cancer research and clinical oncology, 2023, Volume: 149, Issue:11

    Topics: Administration, Intravesical; Gemcitabine; Hematuria; Humans; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Non-Muscle Invasive Bladder Neoplasms; Urinary Bladder Neoplasms

2023